Tyra Biosciences (TYRA) Current Assets (2020 - 2026)

Tyra Biosciences' Current Assets history runs 7 years deep, the most recent figure standing at $394.6 million for Q1 2026.

• Quarterly Current Assets rose 21.58% year-over-year to $394.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $394.6 million (up 21.58% YoY) and the FY2025 annual result came in at $265.4 million, down 23.6% from the prior year.
• Current Assets was $394.6 million for Q1 2026 at Tyra Biosciences, up from $265.4 million in the prior quarter.
• Across five years, Current Assets topped out at $394.6 million in Q1 2026 and bottomed at $211.7 million in Q4 2023.
• A 5-year average of $298.3 million and a median of $281.2 million in 2025 frame the typical range for Current Assets.
• Annual changes were most pronounced in 2024 — Current Assets jumped 64.15% — and 2025, when it retreated 23.6%.
• Tyra Biosciences' Current Assets stood at $257.3 million in 2022, then decreased by 17.73% to $211.7 million in 2023, then soared by 64.15% to $347.5 million in 2024, then declined by 23.6% to $265.4 million in 2025, then surged by 48.66% to $394.6 million in 2026.
• Business Quant data shows TYRA's Current Assets at $394.6 million in Q1 2026, $265.4 million in Q4 2025, and $281.2 million in Q3 2025.